NEKTAR THERAPEUTICS — Director's Dealing 2025

Jan 18, 2025

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2024-12-31

Reporting Person: CHESS ROBERT (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-18	Stock Option	$1.26	A	120000	Acquired	2032-09-17	Common Stock (120000)	Direct

Footnotes

F1: This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.